“For someone...with PPP, there really is hope. Things can be so much better once you have a treatment plan in place.”
You may face a lot of stress as you try to find a diagnosis and treatment plan for PPP. The good news is that developing a treatment plan focused on both today and the future can help.
Work with your doctor to find the best PPP treatment plan for you. Remember that your treatment plan should include long-term attack prevention strategies and guidance for managing episodes when they arise.1
Therapeutic options that reduce the number and severity of PPP episodes are recommended for long-term maintenance.1 Preventing attacks through medication may help you gain more control over your PPP and engage more fully in life.
KEVEYIS is proven to help reduce the number, severity and duration of PPP attacks.2,3
Certain factors, known as triggers, can cause a PPP episode.1 In addition to preventing attacks with medication, learning to identify your triggers can help you better manage episodes. Common triggers include:
PPP episodes may involve a decrease in potassium levels.1,4
Take potassium supplements as recommended by a healthcare provider.1,4 Eat a low sodium, low carbohydrate diet.
Eat frequent carbohydrate-heavy meals.1,4 Avoid potassium-rich foods.
Attacks of muscle stiffness that occur during activity such as exercise5
Avoid cold temperatures and strenuous exercise4
Characterized by muscle weakness, changes in heartbeat, and distinct skeletal features.1,6 It is associated with low, normal, or high potassium levels during an episode.
Light exercise may help decrease the severity of an episode6
"Be patient with yourself, be forgiving... There are all sorts of help, advice, tools available to manage [PPP] and things will improve."
Use the Daily Tracker Tool to record details of your PPP episodes. This can help you determine if something is a trigger or if a management strategy is working. The tracker also includes a 1-Month Diary.
KEVEYIS (dichlorphenamide) is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and other similar diseases.
For more information, see full Prescribing Information for KEVEYIS.
Keveyis®, Xeris Pharmaceuticals®, Xeris CareConnection™, PPP MentorConnect™, and their associated logos are trademarks owned by or licensed to Xeris Pharmaceuticals, Inc.
By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.
